Trial Profile
Efficacy and action mechanism of Imrecoxib in the treatment of axial spondyloarthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2016
Price :
$35
*
At a glance
- Drugs Imrecoxib (Primary) ; Celecoxib
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 12 Nov 2016 Status changed from recruiting to completed.
- 02 Jun 2014 New trial record